Wholesalers are asked to report key details on suspicious orders of controlled substances – The Script

Go to the full article:
Wholesalers are asked to report key details on suspicious orders of controlled substances – The Script July 2018 p. 13 (a publication of the California State Board of Pharmacy)

“A wholesaler, upon discovery, shall notify the board in writing of any suspicious orders of controlled substances placed by a California-licensed pharmacy or wholesaler by providing the board a copy of the information that the wholesaler provides to the United States Drug Enforcement Administration.  Suspicious orders include, but are not limited to, orders of unusual size, orders deviating substantially from a normal pattern, and orders of unusual frequency.”

The Board requests, ” . . . that reports include explicit information as to why the wholesaler deemed the order suspicious. For example, indicate if (1) the order was of an unusual size, (2) the order deviated substantially from the normal pattern, or (3) the order was of an unusual frequency.”

Reference:   On Oct.
7, 2017, Governor Brown signed
into law Assembly Bill 401.
This bill added Business and
Professions Code section 4169.1


Go to DREprof.com: The Designated Representative and Exemptee Training Website

How Well Do You Understand Your Cargo Theft Threats? | iwla1891

The Threat of Cargo Thefts – Does this affect third party logistics (3PL)?

“Cargo theft affects businesses across the globe. Beyond the direct cost of the stolen goods, missing cargo can have far-reaching supply chain implications. Threats to your company’s cargo can vary by commodity type, region and even day of the week. Understanding your product’s susceptibility to theft and developing appropriate strategies to reduce it can help protect your cargo and your business.”

Read the full article – Source: How Well Do You Understand Your Cargo Theft Threats? | iwla1891


Go to DREprof.com: The Designated Representative and Exemptee Training Website

Big Selection Of California Designated Representative Training Courses

Earn a training affidavit – We offer the largest selection of California Designated Representative training programs!

The California Board of Pharmacy oversees a wide range of Designated Representative licenses, including:

  • Designated Representative (for wholesalers)
  • Designated Representative 3PL (for third-party logistics providers), and
  • Designated Representative Reverse Distributor

Each of the three distinct license applications requires proof of training program completion. Specifically, license applicants must submit a training affidavit with their application submission. We offer three (3) different Designated Representative training courses because each license application “type” requires the coverage of different subjects and topics.

Learn more and buy: Training Programs for California Designated Representative License Applicants – Earn a training affidavit

Visit: California Board of Pharmacy – Designated Representative License Application Forms


Go to DREprof.com: The Designated Representative and Exemptee Training Website

California Designated Representative Training Programs

Find California Designated Representative Training Programs – Earn a training affidavit

Question:  Who offers California Designated Representative training courses?

AnswerSkillsPlus International Inc. offers these popular online classes:


Go to DREprof.com: The Designated Representative and Exemptee Training Website

AmerisourceBergen snaps up independent wholesaler H. D. Smith for $815M | FiercePharma

“In the face of a tough pricing market that has weighed on generic drugmakers and their distributors, wholesaling giant AmerisourceBergen has decided to go out and snarf up a bigger share. It will pay $815 million in cash for H. D. Smith, the largest independent drug distributor left in the U.S.”

Source: AmerisourceBergen snaps up independent wholesaler H. D. Smith for $815M | FiercePharma


Go to DREprof.com: The Designated Representative and Exemptee Training Website

Amazon Has Obtained Pharmaceutical Wholesaler Licenses In 12 States – Consumerist

“The Post-Dispatch was able to confirm through public records that Amazon has been approved as a pharmaceutical wholesaler in the states of Alabama, Arizona, Connecticut, Idaho, Louisiana, Michigan, Nevada, New Hampshire, New Jersey, North Dakota, Oregon, and Tennessee. An application in Maine is still pending.”

Source: Amazon Has Obtained Pharmaceutical Wholesaler Licenses In 12 States – Consumerist


Go to DREprof.com: The Designated Representative and Exemptee Training Website

New ATA report takes a deep dive into the ongoing truck driver shortage – Logistics Management

“So, what about those future numbers? You may want to cover your eyes, as they are not pretty. According to the ATA, the driver shortage is projected to hit 50,000 by the end of 2017, with the possibility, if things remain the same, that the number could exceed 174,000 by 2026.”

Source: New ATA report takes a deep dive into the ongoing truck driver shortage – Logistics Management


Go to DREprof.com: The Designated Representative and Exemptee Training Website

California wants to pull Cardinal Health license over ‘red flags’

“The state of California wants to revoke the wholesale license for a facility run by Cardinal Health, one of the nation’s largest pharmaceutical distributors, for failing to note a series of unusual sales of an opioid painkiller and three other tightly regulated medicines to a pharmacy.”

Source: California wants to pull Cardinal Health license over ‘red flags’


Go to DREprof.com: The Designated Representative and Exemptee Training Website

Drug Distributor Profits Will Remain Weak, Says New Drug Channels Institute Study

“We project that U.S. drug distribution revenues at the Big Three public wholesalers—AmerisourceBergen, Cardinal Health, and McKesson—will reach $425 billion in 2017, a 4.5% increase from the 2016 figure.” said Drug Channels Institute CEO Adam J. Fein, Ph.D., the study’s author and a widely regarded expert on pharmaceutical economics and the drug distribution system. “This is the slowest revenue growth since 2013. We also estimate that core U.S. drug distribution margins peaked in 2015 and have declined ever since.”

Source: Drug Distributor Profits Will Remain Weak, Says New Drug Channels Institute Study


Go to DREprof.com: The Designated Representative and Exemptee Training Website

FDA Clarifies DSCSA Entities And Trading Partners

Entities & Trading Partners Defined Under The DSCSA

“The Food and Drug Administration (FDA or the Agency) is issuing this guidance to assist industry and State and local governments in understanding how to categorize the entities in the drug supply chain in accordance with the Drug Supply Chain Security Act (DSCSA). DSCSA establishes product tracing requirements for certain trading partners in the drug supply chain, including manufacturers, repackagers, wholesale distributors, and dispensers. DSCSA also requires that trading partners of manufacturers, wholesale distributors, dispensers, and repackagers must meet the applicable requirements for being “authorized trading partners.” DSCSA also requires FDA to issue regulations that establish Federal standards for the licensing of wholesale drug distributors (WDDs) and third-party logistics providers (3PLs). The Agency is currently drafting these regulations. This guidance, when finalized, will explain FDA’s current thinking on how licensing and certain other requirements apply to entities that may be considered trading partners in the drug supply chain.

This guidance is intended to (1) assist industry and State and local governments in understanding the applicability of DSCSA requirements to the various types of entities that take part in the distribution of prescription drugs in the United States, and (2) help clarify for industry whether they are engaged in activities that require licensure and annual reporting, as well as other requirements related to being an authorized trading partner in the drug supply chain. The guidance does not address all requirements described in DSCSA, but is limited to describing the activities that would determine what type of trading partner an entity may be and the applicable requirements under DSCSA.”

Source:
Identifying Trading Partners Under the Drug Supply Chain Security Act – Guidance for Industry – DRAFT GUIDANCE (PDF)


Go to DREprof.com: The Designated Representative and Exemptee Training Website